Bank of New York Mellon
TELA icon

Bank of New York Mellon’s TELA Bio TELA Stock Holding History

Bank of New York Mellon’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,385
Closed -$240K – 4259
2024
Q1 		$240K Sell
42,385
-6,127
-13% -$40.4K ﹤0.01% 3877
2023
Q4 		$321K Buy
48,512
+2,210
+5% +$12.8K ﹤0.01% 3768
2023
Q3 		$370K Buy
46,302
+710
+2% +$6.6K ﹤0.01% 3706
2023
Q2 		$462K Buy
+45,592
New +$466K ﹤0.01% 3642
2021
Q2 		– Sell
-12,204
Closed -$182K – 4470
2021
Q1 		$182K Hold
12,204
– – ﹤0.01% 4080
2020
Q4 		$184K Buy
12,204
+54
+0.4% +$876 ﹤0.01% 3995
2020
Q3 		$201K Hold
12,150
– – ﹤0.01% 3846
2020
Q2 		$157K Buy
+12,150
New +$160K ﹤0.01% 3851

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bank of New York Mellon's TELA Position: Q2 2024 in Review

Bank of New York Mellon sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 42,385 shares — an estimated $240K sold.

Bank of New York Mellon first reported a position in TELA in Q2 2020 and held it in 8 quarters. The position peaked at $462K in Q2 2023. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Bank of New York Mellon reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 42,385 TELA Bio shares in Q2 2024, an estimated $240K.
  • Bank of New York Mellon first reported a position in TELA Bio in Q2 2020 and held it in 8 quarters.
  • Bank of New York Mellon's TELA Bio position peaked at $462K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.